Cargando…

Progress in mesenchymal stem cell–based therapy for acute liver failure

Acute liver failure is a life-threatening clinical syndrome characterized by rapid development of hepatocellular necrosis leading to high mortality and resource costs. Numerous treatment strategies for acute liver failure simply prevent complications and decelerate disease progression. The only cura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yong-Hong, Wu, Dong-Bo, Chen, Bing, Chen, En-Qiang, Tang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109312/ https://www.ncbi.nlm.nih.gov/pubmed/30143052 http://dx.doi.org/10.1186/s13287-018-0972-4

Ejemplares similares

Mesenchymal Stem Cell Therapy in Acute Liver Failure
por: Wang, Yong-Hong, et al.
Publicado: (2023)

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature
por: Wu, Dong-Bo, et al.
Publicado: (2017)

Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway
por: Tao, Ya-Chao, et al.
Publicado: (2022)

Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo
por: Wang, Yong-Hong, et al.
Publicado: (2021)

Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure
por: Yang, Hui, et al.
Publicado: (2023)

Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
por: Ho, Cheng-Maw, et al.
Publicado: (2020)

The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023)

Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure
por: Chen, En-Qiang, et al.
Publicado: (2017)

Neutrophil–lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system
por: Fan, Zeng, et al.
Publicado: (2017)

Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys
por: Guo, Gang, et al.
Publicado: (2019)

Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide
por: Jiang, Ting, et al.
Publicado: (2022)

Perspective of placenta derived mesenchymal stem cells in acute liver failure
por: Saleh, Mahshid, et al.
Publicado: (2020)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Wang, Meng-Lan, et al.
Publicado: (2021)

Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
por: Li, Tian-Tian, et al.
Publicado: (2022)

Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway
por: Tao, Ya-Chao, et al.
Publicado: (2019)

Adipose Derived Mesenchymal Stem Cells Efficiently Rescue Carbon Tetrachloride-Induced Acute Liver Failure in Mouse
por: Deng, Lisi, et al.
Publicado: (2014)

The Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of Acute Liver Failure
por: Yuan, Shufang, et al.
Publicado: (2013)

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure
por: Xu, Ruixuan, et al.
Publicado: (2022)

The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials
por: Liu, Yuwei, et al.
Publicado: (2022)

Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications
por: Chen, En-Qiang, et al.
Publicado: (2018)

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)

The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis
por: Zhang, Ka, et al.
Publicado: (2021)

A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure
por: Zhu, Bing, et al.
Publicado: (2020)

Application of mesenchymal stem cell exosomes and their drug‐loading systems in acute liver failure
por: Zhang, Shuqin, et al.
Publicado: (2020)

In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway
por: Wang, Lu, et al.
Publicado: (2019)

Comparing the Therapeutic Mechanism and Immune Response of Human and Mouse Mesenchymal Stem Cells in Immunocompetent Mice With Acute Liver Failure
por: Wang, Chang-Hung, et al.
Publicado: (2023)

Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
por: Guo, Yinghan, et al.
Publicado: (2021)

Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury
por: Fu, Zhangning, et al.
Publicado: (2023)

Research Progress on the Role of Probiotics in Acute Liver Failure
por: Xue, Chen, et al.
Publicado: (2022)

Adipose-derived stem cell-based treatment for acute liver failure
por: Chen, Guangfeng, et al.
Publicado: (2015)

Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure
por: Zhou, Jia-Hang, et al.
Publicado: (2021)

Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure
por: Tang, Yunxia, et al.
Publicado: (2016)

Mesenchymal Stem Cells Improve Glycometabolism and Liver Regeneration in the Treatment of Post-hepatectomy Liver Failure
por: Ding, Hao-ran, et al.
Publicado: (2019)

IL-1β Pretreatment Improves the Efficacy of Mesenchymal Stem Cells on Acute Liver Failure by Enhancing CXCR4 Expression
por: Nie, He, et al.
Publicado: (2020)

Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure
por: Wang, Jie, et al.
Publicado: (2017)

Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure
por: Li, Chen, et al.
Publicado: (2018)

Mesenchymal stem cells-based therapy in liver diseases
por: Han, Heng-Tong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gg6lfjd1ai3u281dps8o8oksa2